SomnoMed Limited
SOMNF
$0.4361
-$0.0487-10.05%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 2.82% | 98.18% | -0.21% | 6.29% | 0.48% |
Total Depreciation and Amortization | -2.75% | 37.55% | 0.21% | -24.64% | -0.47% |
Total Amortization of Deferred Charges | -- | -- | 0.21% | -- | -- |
Total Other Non-Cash Items | -2.75% | -2.83% | 0.21% | 216.73% | 0.49% |
Change in Net Operating Assets | -- | -- | -0.20% | -- | -- |
Cash from Operations | -2.75% | 335.71% | -0.21% | 61.21% | 0.48% |
Capital Expenditure | 2.77% | 23.79% | -0.18% | -65.94% | 0.52% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 2.75% | 67.01% | -0.20% | -36.22% | 0.47% |
Cash from Investing | 2.76% | 55.12% | -0.20% | -43.27% | 0.48% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | 0.00% | 88.61% | 0.00% | -105.17% | 0.00% |
Issuance of Common Stock | -- | -- | 0.00% | 61.28% | 0.00% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 0.00% | 97.86% | 0.00% | -- | -- |
Cash from Financing | 2.74% | -118.37% | 0.21% | 3.32% | -0.47% |
Foreign Exchange rate Adjustments | -2.75% | 673.81% | -0.15% | 64.38% | 0.48% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -2.75% | -29.41% | 0.20% | 282.69% | -0.49% |